|
| Status |
Public on Nov 13, 2021 |
| Title |
genomic DNA from glioblastoma 96 |
| Sample type |
genomic |
| |
|
| Source name |
glioblastoma 96
|
| Organism |
Homo sapiens |
| Characteristics |
diagnosis: glioblastoma
gender: male
age: 75
idh: wildtype
|
| Treatment protocol |
Standard Illumina EPIC Protocol
|
| Extracted molecule |
genomic DNA |
| Extraction protocol |
genomic DNA was extracted and purified from LBC samples using Qiagen DNeasy Kit according to standard instructions
|
| Label |
Cy5 and Cy3
|
| Label protocol |
Standard Illumina EPIC Protocol
|
| |
|
| Hybridization protocol |
bisulphite converted DNA was amplified, fragmented and hybridised to Illumina Infinium Human Methylation27 Beadchip using standard Illumina protocol
|
| Scan protocol |
Arrays were imaged using BeadArray Reader using standard recommended Illumina scanner setting
|
| Data processing |
BeadStudio software v3.2
|
| |
|
| Submission date |
Nov 10, 2021 |
| Last update date |
Nov 14, 2021 |
| Contact name |
Richard Drexler |
| E-mail(s) |
r.drexler@uke.de
|
| Organization name |
Medical Center Hamburg-Eppendorf
|
| Department |
Neurosurgery
|
| Street address |
Martinistraße 52
|
| City |
Hamburg |
| ZIP/Postal code |
20246 |
| Country |
Germany |
| |
|
| Platform ID |
GPL21145 |
| Series (1) |
| GSE188547 |
DNA Methylation subclass Receptor Tyrosine Kinase II (RTK II) is predictive for seizure development in glioblastoma patients |
|
